Annovis Bio (ANVS)
(Delayed Data from NYSE)
$6.00 USD
0.00 (0.00%)
Updated May 30, 2024 04:00 PM ET
After-Market: $5.97 -0.03 (-0.50%) 5:40 PM ET
2-Buy of 5 2
F Value C Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/20/2024
Time: -- |
6/2024 | $-0.70 | 0.00% |
Earnings Summary
For their last quarter, Annovis Bio (ANVS) reported earnings of -$0.72 per share, beating the Zacks Consensus Estimate of $-0.87 per share. This reflects a positive earnings surprise of 17.24%. Look out for ANVS's next earnings release expected on August 20, 2024. For the next earning release, we expect the company to report earnings of -$0.70 per share, reflecting a year-over-year increase of 34.58%.
Earnings History
Price & Consensus
Zacks News for ANVS
Prothena (PRTA), Bristol Myers Tie Up for Second Neuro Candidate
ANVS: What are Zacks experts saying now?
Zacks Private Portfolio Services